Literature DB >> 33477992

Influence of Personality, Resilience and Life Conditions on Depression and Anxiety in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura.

Tanja Falter1, Sibylle Böschen1, Markus Schepers2, Manfred Beutel3, Karl Lackner1, Inge Scharrer4, Bernhard Lämmle4,5,6.   

Abstract

Autoimmune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening, relapsing disease in which an acquired deficiency of the enzyme ADAMTS13 leads to generalised microvascular thrombosis. Survivors have a high prevalence of depression and impaired cognitive function. The aim of this study was to determine whether life circumstances and personality have an influence on the development and severity of depression and anxiety in iTTP patients and how they impact the quality of life. With validated questionnaires, we examined the prevalence of depression and anxiety symptoms in 104 iTTP patients, as well as parameters of subjective cognitive deficits, quality of life, attitude to life and resilience. iTTP patients had significantly more depressive symptoms (p < 0.001), a tendency to have anxiety disorders (p = 0.035) and a significantly worse cognitive performance (p = 0.008) compared to the controls. Sex, age, physical activity and partnership status had no significant influence on depression, whereas the number of comorbidities did. Lower scores of resilience, attitude to life and quality of life were reported by patients compared to controls. iTTP patients had a high prevalence of depression and anxiety, as well as a more negative attitude to life and low resilience. Resilience correlated negatively with the severity of the depression. Furthermore, quality of life and cognitive performance were significantly reduced.

Entities:  

Keywords:  depression; quality of life; resilience; thrombotic thrombocytopenic purpura

Year:  2021        PMID: 33477992      PMCID: PMC7835833          DOI: 10.3390/jcm10020365

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  41 in total

1.  Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test.

Authors:  M F Scheier; C S Carver; M W Bridges
Journal:  J Pers Soc Psychol       Date:  1994-12

2.  Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura.

Authors:  Tanja Falter; Veronique Schmitt; Stephanie Herold; Veronika Weyer; Charis von Auer; Stefanie Wagner; Gudrun Hefner; Manfred Beutel; Karl Lackner; Bernhard Lämmle; Inge Scharrer
Journal:  Transfusion       Date:  2017-03-24       Impact factor: 3.157

3.  Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura.

Authors:  Spero R Cataland; Marie A Scully; James Paskavitz; Paul Maruff; Leslie Witkoff; Ming Jin; Nicholas Uva; James C Gilbert; Haifeng M Wu
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

4.  The science of resilience: implications for the prevention and treatment of depression.

Authors:  Steven M Southwick; Dennis S Charney
Journal:  Science       Date:  2012-10-05       Impact factor: 47.728

Review 5.  The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care.

Authors:  J N George; S K Vesely; D R Terrell; C C Deford; J A Reese; Z L Al-Nouri; L M Stewart; K H Lu; D S Muthurajah
Journal:  Hamostaseologie       Date:  2013-01-31       Impact factor: 1.778

6.  Low psychological resilience is associated with depression in patients with cardiovascular disease.

Authors:  S R Toukhsati; A Jovanovic; S Dehghani; T Tran; A Tran; D L Hare
Journal:  Eur J Cardiovasc Nurs       Date:  2016-07-08       Impact factor: 3.908

Review 7.  Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.

Authors:  James T B Crawley; Marie A Scully
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

8.  Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Silvia Riva; Ilaria Mancini; Alberto Maino; Barbara Ferrari; Andrea Artoni; Pasquale Agosti; Flora Peyvandi
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

9.  Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study.

Authors:  Paul Knoebl; Spero Cataland; Flora Peyvandi; Paul Coppo; Marie Scully; Johanna A Kremer Hovinga; Ara Metjian; Javier de la Rubia; Katerina Pavenski; Jessica Minkue Mi Edou; Hilde De Winter; Filip Callewaert
Journal:  J Thromb Haemost       Date:  2019-12-09       Impact factor: 5.824

10.  Relationship between resilience, social support as well as anxiety/depression of lung cancer patients: A cross-sectional observation study.

Authors:  Tingjie Hu; Jian Xiao; Juan Peng; Xiao Kuang; Bixiu He
Journal:  J Cancer Res Ther       Date:  2018-01       Impact factor: 1.805

View more
  1 in total

Review 1.  TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Authors:  Nuno A G Graça; Bérangère S Joly; Jan Voorberg; Karen Vanhoorelbeke; Nicolas Béranger; Agnès Veyradier; Paul Coppo
Journal:  Br J Haematol       Date:  2022-02-10       Impact factor: 8.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.